
Meta is being sued by 26 former employees who claim the company used AI tools to unfairly target workers on leave for layoffs. The lawsuit alleges that Meta's AI systems ranked employee performance without excluding those on parental or medical leave, resulting in biased layoff decisions. These layoffs were part of a broader plan to reduce Meta's workforce by 10 percent. Meta denies the claims, stating that human decision-making was responsible for the layoffs. The case raises concerns about the use of AI in HR processes.
Read original
© The Verge AIOpenAI is reportedly developing a smart speaker that integrates ChatGPT, aiming for a 2027 release. This device, lacking a screen but equipped with a camera and sensors, is designed to interact with users in a more humanlike manner. It will feature GPT-Live, OpenAI's latest voice model, and offer functionalities like smart home control and media playback. The collaboration with former Apple designer Jony Ive suggests a focus on innovative design, marking OpenAI's significant entry into the hardware market. This move could redefine how AI integrates into everyday environments.
© The Verge AISpaceXAI's Grok Build AI tool was discovered to be uploading entire user codebases to Google Cloud, including files that were supposed to be excluded and sensitive information. This practice went beyond typical data retention norms, raising significant privacy concerns. After the issue was reported by Cereblab, SpaceXAI disabled the feature, and Elon Musk assured users that all previously uploaded data would be deleted. This situation underscores the critical need for robust data privacy measures in AI tools, especially those handling proprietary and sensitive data. The incident serves as a reminder of the potential risks associated with excessive data retention in AI development environments. SpaceXAI's response and Musk's commitment to data deletion reflect the importance of transparency and user control over data.
© The Verge AIGoogle is transforming its Images homepage into a dynamic, personalized gallery, marking a significant shift from its traditional search bar interface. This new feature will present users with a curated selection of images tailored to their interests, reminiscent of platforms like Pinterest. Additionally, Google Search will soon leverage its Nano Banana 2 Lite AI model to generate images in AI Overviews, enhancing visualization capabilities for users. These updates aim to make image discovery more intuitive and engaging, offering a more interactive experience for users even before they initiate a search.
© SiftedNeko Health has successfully raised $700 million in Series C funding, marking a pivotal moment for the company. With 100,000 members and profitability at the clinic level, this funding round is a testament to the company's robust growth and operational success. The investment is set to drive further expansion and innovation in their healthcare services, potentially reshaping the landscape of healthcare delivery. Neko Health's strategic position in the health tech industry is strengthened by this substantial financial backing, which reflects strong investor belief in its business model and future trajectory.
© SiftedMeticulous, a London-based startup, has secured $15 million in Series A funding to advance its AI-driven code testing platform. Founded by ex-Palantir and Dropbox engineers, the company aims to streamline the process of verifying AI-generated code by simulating user flows and identifying edge cases. This approach allows developers to quickly understand the impact of code changes, potentially accelerating the deployment process. With plans to expand into backend testing and grow its team, Meticulous is positioning itself as a key player in the AI code verification space.
© TechCrunch AIMiles Wang, an OpenAI researcher, is reportedly leaving to start a new AI-driven drug discovery company, potentially valued at $2 billion. This move highlights the growing trend of applying AI to accelerate breakthroughs in life sciences, with Wang's startup aiming to repurpose existing drugs for new uses. While the funding details are still in flux, the interest from investors like Lightspeed shows the potential impact of AI in the pharmaceutical industry. If successful, Wang's venture could significantly reduce the time and cost associated with bringing new treatments to market.